Alejandro Balsa

14.8k total citations
285 papers, 6.1k citations indexed

About

Alejandro Balsa is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alejandro Balsa has authored 285 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Rheumatology, 103 papers in Immunology and 54 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alejandro Balsa's work include Rheumatoid Arthritis Research and Therapies (162 papers), Systemic Lupus Erythematosus Research (77 papers) and Monoclonal and Polyclonal Antibodies Research (52 papers). Alejandro Balsa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (162 papers), Systemic Lupus Erythematosus Research (77 papers) and Monoclonal and Polyclonal Antibodies Research (52 papers). Alejandro Balsa collaborates with scholars based in Spain, United States and France. Alejandro Balsa's co-authors include Dora Pascual‐Salcedo, E. Martín‐Mola, Javier Martı́n, Isidoro González‐Álvaro, Miguel Á. González‐Gay, María‐Eugenia Miranda‐Carús, Raimón Sanmartí, Laura Nuño, Loreto Carmona and Benjamín Fernández‐Gutiérrez and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and The Journal of Immunology.

In The Last Decade

Alejandro Balsa

277 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Balsa Spain	43	3.3k	2.4k	962	920	783	285	6.1k
Jacob M. van Laar Netherlands	47	2.5k 0.8×	2.4k 1.0×	1.1k 1.2×	910 1.0×	628 0.8×	251	7.5k
Alexandre E. Voskuyl Netherlands	50	5.6k 1.7×	2.2k 0.9×	1.0k 1.1×	1.2k 1.3×	1.0k 1.3×	246	9.2k
Marc Bijl Netherlands	49	3.4k 1.0×	3.4k 1.5×	886 0.9×	674 0.7×	961 1.2×	154	6.7k
W. Joseph McCune United States	43	3.6k 1.1×	3.1k 1.3×	944 1.0×	471 0.5×	881 1.1×	99	6.2k
Jacques‐Eric Gottenberg France	46	2.7k 0.8×	1.7k 0.7×	1.0k 1.1×	545 0.6×	387 0.5×	163	7.1k
Maya H Buch United Kingdom	42	3.9k 1.2×	1.7k 0.7×	560 0.6×	1.4k 1.5×	709 0.9×	211	6.4k
Prodromos Sidiropoulos Greece	41	2.9k 0.9×	2.4k 1.0×	1.1k 1.2×	594 0.6×	372 0.5×	164	5.4k
Rosalind Ramsey‐Goldman United States	51	5.7k 1.7×	3.8k 1.6×	779 0.8×	629 0.7×	1.4k 1.8×	208	8.4k
Dae‐Hyun Yoo South Korea	35	2.2k 0.7×	2.8k 1.2×	618 0.6×	688 0.7×	464 0.6×	198	5.3k
Dario Roccatello Italy	43	3.1k 0.9×	1.3k 0.6×	737 0.8×	1.5k 1.6×	588 0.8×	357	6.8k

Countries citing papers authored by Alejandro Balsa

Since Specialization

Citations

This map shows the geographic impact of Alejandro Balsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Balsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Balsa more than expected).

Fields of papers citing papers by Alejandro Balsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Balsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Balsa. The network helps show where Alejandro Balsa may publish in the future.

Co-authorship network of co-authors of Alejandro Balsa

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Balsa. A scholar is included among the top collaborators of Alejandro Balsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Balsa. Alejandro Balsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Edwards, Christopher, Gerhard Krönke, Jérôme Avouac, et al.. (2025). Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study. The Journal of Rheumatology. 52(4). jrheum.2024–906. 1 indexed citations

Li, Chengyi, Shuai Mao, Alejandro Balsa, et al.. (2025). SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation. ACS Nano. 19(7). 7038–7054. 3 indexed citations

Taylor, Peter C., Alejandro Balsa, Anne‐Barbara Mongey, et al.. (2024). Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary. Rheumatology and Therapy. 11(6). 1425–1435. 1 indexed citations

Smolen, Josef S, Peter C. Taylor, Yoshiya Tanaka, et al.. (2024). Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis. Lara D. Veeken. 63(11). 3015–3024. 6 indexed citations

Novella-Navarro, Marta, Virginia Ruíz-Esquide, I. Monjo, et al.. (2024). Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical Rheumatology. 43(9). 2817–2823. 1 indexed citations

Avouac, Jérôme, Hubert Marotte, Alejandro Balsa, et al.. (2023). Teleconsultation in rheumatology: A literature review and opinion paper. Seminars in Arthritis and Rheumatism. 63. 152271–152271. 5 indexed citations

Novella-Navarro, Marta, Alejandro Villalba, Elisa Fernández-Fernández, et al.. (2023). Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment. RMD Open. 9(3). e003382–e003382. 7 indexed citations

Benavent, Diego, Dora Pascual‐Salcedo, Chamaida Plasencia‐Rodríguez, et al.. (2023). Translation and cross-cultural adaptation of the mSQUASH into Spanish. Reumatología Clínica. 19(8). 436–441. 2 indexed citations

Cordero, Oscar J., Irene Viéitez, Laura Nuño, et al.. (2022). Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients. Archivum Immunologiae et Therapiae Experimentalis. 70(1). 12–12. 1 indexed citations

10.

Monjo, I., Elisa Fernández-Fernández, Diana Peiteado, Alejandro Balsa, & Eugenio de Miguel. (2022). Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis. Clinical Rheumatology. 42(4). 1163–1169. 11 indexed citations

11.

Benavent, Diego, Chamaida Plasencia‐Rodríguez, Marta Novella-Navarro, et al.. (2022). Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain. BMJ Open. 12(4). e057850–e057850. 10 indexed citations

12.

Hernández‐Breijo, Borja, Ioannis Parodis, Marta Novella-Navarro, et al.. (2022). Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis. Journal of Clinical Medicine. 11(17). 5207–5207. 5 indexed citations

13.

Krieckaert, C., Borja Hernández‐Breijo, Johanna Elin Gehin, et al.. (2022). Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider. RMD Open. 8(2). e002216–e002216. 16 indexed citations

14.

Taylor, Peter C., et al.. (2019). How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy. Journal of Clinical Medicine. 8(4). 515–515. 61 indexed citations

15.

Benito, Marta, Diana Peiteado, Alejandro Balsa, et al.. (2017). FRI0062 Synovial fluid treg cells secrete il-17 and at the same time are potent suppressors of tresp cell proliferation, tnf alpha and ifn gamma production. Annals of the Rheumatic Diseases. 76. 501–502.

16.

Torices, Silvia, Lorena Álvarez‐Rodríguez, Lara Grande, et al.. (2015). A Truncated Variant of ASCC1, a Novel Inhibitor of NF-κB, Is Associated with Disease Severity in Patients with Rheumatoid Arthritis. The Journal of Immunology. 195(11). 5415–5420. 18 indexed citations

17.

Plasencia, Chamaida, Dora Pascual‐Salcedo, Laura Nuño, et al.. (2012). Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab. Annals of the Rheumatic Diseases. 71(12). 1955–1960. 92 indexed citations

18.

García-Bermúdez, Mercedes, C González-Juanatey, Luis Rodríguez‐Rodríguez, et al.. (2011). Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.. PubMed. 29(4). 681–8. 12 indexed citations

19.

Naranjo, Antonio, Loreto Carmona, Diana Gavrila, et al.. (2004). Prevalence and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients.. PubMed. 22(4). 427–32. 36 indexed citations

20.

Balsa, Alejandro, et al.. (1988). Osteomielitis crónica multifocal recurrente. Anales de Pediatría. 29(4). 339–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact